Cargando…

Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation

BACKGROUND: Non-traditional CD4+CD25–CD69+ T cells were found to be involved in disease progression in tumor-bearing mouse models and cancer patients recently. We attempted to define whether this subset of T cells were related to leukemia relapse after allogeneic hematopoietic cell transplantation (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiao-su, Wang, Xu-hua, Zhao, Xiang-yu, Chang, Ying-jun, Xu, Lan-ping, Zhang, Xiao-hui, Huang, Xiao-jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089938/
https://www.ncbi.nlm.nih.gov/pubmed/24984576
http://dx.doi.org/10.1186/1479-5876-12-187
_version_ 1782325201298522112
author Zhao, Xiao-su
Wang, Xu-hua
Zhao, Xiang-yu
Chang, Ying-jun
Xu, Lan-ping
Zhang, Xiao-hui
Huang, Xiao-jun
author_facet Zhao, Xiao-su
Wang, Xu-hua
Zhao, Xiang-yu
Chang, Ying-jun
Xu, Lan-ping
Zhang, Xiao-hui
Huang, Xiao-jun
author_sort Zhao, Xiao-su
collection PubMed
description BACKGROUND: Non-traditional CD4+CD25–CD69+ T cells were found to be involved in disease progression in tumor-bearing mouse models and cancer patients recently. We attempted to define whether this subset of T cells were related to leukemia relapse after allogeneic hematopoietic cell transplantation (allo-HSCT). METHODS: The frequency of CD4+CD25–CD69+ T cells among the CD4+ T cell population from the bone marrow of relapsed patients, patients with positive minimal residual disease (MRD+) and healthy donors was examined by flow cytometry. The CD4+CD25-CD69+ T cells were also stained with the intracellular markers to determine the cytokine (TGF-β, IL-2 and IL-10) secretion. RESULTS: The results showed that the frequency of CD4+CD25–CD69 + T cells was markedly increased in patients in the relapsed group and the MRD + group compared to the healthy donor group. The percentage of this subset of T cells was significantly decreased after effective intervention treatment. We also analyzed the reconstitution of CD4+CD25–CD69+ T cells at various time points after allo-HSCT, and the results showed that this subset of T cells reconstituted rapidly and reached a relatively higher level at +60 d in patients compared to controls. The incidence of either MRD+ or relapse in patients with a high frequency of CD4+CD25-CD69+ T cells (>7%) was significantly higher than that of patients with a low frequency of CD4+CD25-CD69+ T cells at +60 d, +90 d and +270 d after transplant. However, our preliminary data indicated that CD4+CD25-CD69+ T cells may not exert immunoregulatory function via cytokine secretion. CONCLUSIONS: This study provides the first clinical evidence of a correlation between non-traditional CD4+CD25-CD69+ Tregs and leukemia relapse after allo-HSCT and suggests that exploration of new methods of adoptive immunotherapy may be beneficial. Further research related to regulatory mechanism behind this phenomenon would be necessary.
format Online
Article
Text
id pubmed-4089938
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40899382014-07-10 Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation Zhao, Xiao-su Wang, Xu-hua Zhao, Xiang-yu Chang, Ying-jun Xu, Lan-ping Zhang, Xiao-hui Huang, Xiao-jun J Transl Med Research BACKGROUND: Non-traditional CD4+CD25–CD69+ T cells were found to be involved in disease progression in tumor-bearing mouse models and cancer patients recently. We attempted to define whether this subset of T cells were related to leukemia relapse after allogeneic hematopoietic cell transplantation (allo-HSCT). METHODS: The frequency of CD4+CD25–CD69+ T cells among the CD4+ T cell population from the bone marrow of relapsed patients, patients with positive minimal residual disease (MRD+) and healthy donors was examined by flow cytometry. The CD4+CD25-CD69+ T cells were also stained with the intracellular markers to determine the cytokine (TGF-β, IL-2 and IL-10) secretion. RESULTS: The results showed that the frequency of CD4+CD25–CD69 + T cells was markedly increased in patients in the relapsed group and the MRD + group compared to the healthy donor group. The percentage of this subset of T cells was significantly decreased after effective intervention treatment. We also analyzed the reconstitution of CD4+CD25–CD69+ T cells at various time points after allo-HSCT, and the results showed that this subset of T cells reconstituted rapidly and reached a relatively higher level at +60 d in patients compared to controls. The incidence of either MRD+ or relapse in patients with a high frequency of CD4+CD25-CD69+ T cells (>7%) was significantly higher than that of patients with a low frequency of CD4+CD25-CD69+ T cells at +60 d, +90 d and +270 d after transplant. However, our preliminary data indicated that CD4+CD25-CD69+ T cells may not exert immunoregulatory function via cytokine secretion. CONCLUSIONS: This study provides the first clinical evidence of a correlation between non-traditional CD4+CD25-CD69+ Tregs and leukemia relapse after allo-HSCT and suggests that exploration of new methods of adoptive immunotherapy may be beneficial. Further research related to regulatory mechanism behind this phenomenon would be necessary. BioMed Central 2014-07-01 /pmc/articles/PMC4089938/ /pubmed/24984576 http://dx.doi.org/10.1186/1479-5876-12-187 Text en Copyright © 2014 Zhao et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhao, Xiao-su
Wang, Xu-hua
Zhao, Xiang-yu
Chang, Ying-jun
Xu, Lan-ping
Zhang, Xiao-hui
Huang, Xiao-jun
Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation
title Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation
title_full Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation
title_fullStr Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation
title_full_unstemmed Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation
title_short Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation
title_sort non-traditional cd4+cd25−cd69+ regulatory t cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089938/
https://www.ncbi.nlm.nih.gov/pubmed/24984576
http://dx.doi.org/10.1186/1479-5876-12-187
work_keys_str_mv AT zhaoxiaosu nontraditionalcd4cd25cd69regulatorytcellsarecorrelatedtoleukemiarelapseafterallogeneichematopoieticstemcelltransplantation
AT wangxuhua nontraditionalcd4cd25cd69regulatorytcellsarecorrelatedtoleukemiarelapseafterallogeneichematopoieticstemcelltransplantation
AT zhaoxiangyu nontraditionalcd4cd25cd69regulatorytcellsarecorrelatedtoleukemiarelapseafterallogeneichematopoieticstemcelltransplantation
AT changyingjun nontraditionalcd4cd25cd69regulatorytcellsarecorrelatedtoleukemiarelapseafterallogeneichematopoieticstemcelltransplantation
AT xulanping nontraditionalcd4cd25cd69regulatorytcellsarecorrelatedtoleukemiarelapseafterallogeneichematopoieticstemcelltransplantation
AT zhangxiaohui nontraditionalcd4cd25cd69regulatorytcellsarecorrelatedtoleukemiarelapseafterallogeneichematopoieticstemcelltransplantation
AT huangxiaojun nontraditionalcd4cd25cd69regulatorytcellsarecorrelatedtoleukemiarelapseafterallogeneichematopoieticstemcelltransplantation